PD-L1/PD-1 Cancer Immunotherapy and New Targets - Gordon Freeman, PhD
![](https://i.ytimg.com/vi/pwCDymYTBnY/mqdefault.jpg)
1:00:33
Antibody responses to SARS-CoV-2 infection and vaccination - Florian Krammer Ph.D.
![](https://i.ytimg.com/vi/FchDco7AO5E/mqdefault.jpg)
1:09:19
Cancer immunotherapy - significant breakthrough or unrealised potential?
![](https://i.ytimg.com/vi/ucKEvSqxNug/mqdefault.jpg)
43:07
Origins and diversity of human bone marrow plasma cells - Duane Wesemann, M.D., Ph.D.
![](https://i.ytimg.com/vi/pFMn8o6rECM/mqdefault.jpg)
7:37
How to interpret a PD-L1 immunostain
![](https://i.ytimg.com/vi/zhnAvTxhZB0/mqdefault.jpg)
1:00:44
Targeting Cancer Pathways: Understanding Immune Checkpoints
![](https://i.ytimg.com/vi/QHl6wYCwlcQ/mqdefault.jpg)
2:29:36
La mejor música clásica relajante de Mozart - Meditación de relajación Lectura Enfoque
![](https://i.ytimg.com/vi/Xq_lQDMoJqY/mqdefault.jpg)
37:26
Cancer Immunotherapy Basics: Understand the science behind this cutting-edge treatment
![](https://i.ytimg.com/vi/toRYM1lLKBc/mqdefault.jpg)
1:27:48